PAG
CLSD

Private Advisor Group’s Clearside Biomedical CLSD Stock Holding History

Private Advisor Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-993
Closed -$17K – 1713
2022
Q3 		$17K Hold
993
– – ﹤0.01% 1882
2022
Q2 		$22K Sell
993
-467
-32% -$11.3K ﹤0.01% 2072
2022
Q1 		$50K Sell
1,460
-73
-5% -$2.18K ﹤0.01% 2041
2021
Q4 		$63K Hold
1,533
– – ﹤0.01% 2064
2021
Q3 		$138K Sell
1,533
-34
-2% -$3K ﹤0.01% 1921
2021
Q2 		$114K Sell
1,567
-100
-6% -$4.65K ﹤0.01% 1895
2021
Q1 		$62K Buy
+1,667
New +$83.7K ﹤0.01% 1836

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Private Advisor Group's CLSD Position: Q4 2022 in Review

Private Advisor Group sold out of Clearside Biomedical (CLSD) in Q4 2022, closing a stake of 993 shares — an estimated $17K sold.

Private Advisor Group first reported a position in CLSD in Q1 2021 and held it in 7 quarters. The position peaked at $138K in Q3 2021. 53 funds tracked by Wall St. Rank hold CLSD as of Q4 2022.

  • Private Advisor Group reported no remaining Clearside Biomedical position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 993 Clearside Biomedical shares in Q4 2022, an estimated $17K.
  • Private Advisor Group first reported a position in Clearside Biomedical in Q1 2021 and held it in 7 quarters.
  • Private Advisor Group's Clearside Biomedical position peaked at $138K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.